Efficacy and Tolerability of Sodium Zirconium Cyclosilicate or Patiromer in Managing Hyperkalemia
Both SZC and patiromer effectively lower serum potassium and provide clinical benefits, with distinct safety considerations. Therapy selection should be guided by treatment goals and the patient's individual risk profile.
Authors
- Wannasit Wathanavasin (ORCID: https://orcid.org/0000-0002-1765-6159)
- Solos Jaturapisanukul (ORCID: https://orcid.org/0000-0003-1993-1369)
- Wisit Cheungpasitporn
- Charat Thongprayoon
Institutions
- Mayo Clinic (US)
- Navamindradhiraj University (TH)
- Bangkok Metropolitan Administration (TH)
- Vajira Hospital (TH)
- Charoenkrung Pracharak Hospital (TH)
Publication Details
- Journal
- Kidney360
- Published
- 2026-03-11
- DOI
- https://doi.org/10.34067/kid.0000001173
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00